The Cigna Group in 2 stories
The narratives CI currently appears in, with its side and exposure in each.
Bull side
1 story- America Imports the World's Drug Prices
CI in “America Imports the World's Drug Prices”
StableExposure: not rated yetUS reference pricing puts global blockbuster economics—and not just American list prices—under pressure.
Cigna's health-benefits and Evernorth pharmacy-services businesses could benefit from lower drug claims and greater negotiating leverage over branded manufacturers.
Bear side
1 story- Managed Care's Margin Machine Breaks
CI in “Managed Care's Margin Machine Breaks”
FadingExposure: not rated yetRising utilization, tougher reimbursement and scrutiny of denials are shifting economics from insurers back to care providers.
Cigna faces regulatory and political pressure on the pharmacy-benefit model that underpins much of its earnings growth.